Most epidemiologists are aware of some of the problems with P-values; they combine both effect size and sample size, they are not easy to interpret, in most studies they really have no meaning and in many cases they are simply grossly misleading causing mistakes that can be serious. Misinterpretation of P values has probably led […]
We have over the years provided comments to rules and regulations for data protection. We have especially provided information on the situation in Europe where new regulations is being negotiated. The rules have crucial importance for our access to use of data for research, especially for use of registers like the cancer Registry or the […]
Follow the links below to find 2 recent important documents about use of data for research. These influential bodies (Nature and ScienceEurope) provide strong support for making legislation that allows reuse of data for research.
Evert Ben van Veen has written a summary of the LIBE views and makes comparisons to the proposed data protection regulation. The LIBE proposal will set back epidemiologic research in many European countries if used in the new law. It will threaten free and critical research and the principles of democracy and open societies. […]
The matter of data protection regulation has been addressed in a workshop at the last WCE in Edinburgh and the impact that the EU proposal may have on the epidemiologists current work has been debated in some recent papers. The opportunity of harmonising data protection procedures among EU countries has been underlined by some researchers […]
Since our last report, several groups have been active in suggesting modification of the text to facilitate epidemiologic research in Europe.
Epidemiologists have contacted members of the European Parliament from their home countries. Ministers of Research have been contacted, and newspaper articles have been published on the topic.
Not only epidemiologists have been active. Large […]
It is well documented that NCDs carry an increasing burden of diseases and mortality in affluent as well as poor countries. NCDs amount to 63 % of all deaths in the world, and 80 % of these occur in low and middle income countries (LMICs). Cardiovascular diseases and chronic obstructive diseases are expected to increase […]